Work

Sipuleucel-T (sip-T) to induce cytolytic T lymphocyte (CTL) activity against target antigens in men with hormone-sensitive and castration-resistant prostate cancer (CRPC).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.5046

Authors: Charles G. Drake, Emmanuel S. Antonarakis, Daniel Peter Petrylak, David I. Quinn, Adam S. Kibel, Nancy N. Chang, Erica Dearstyne, Dwayne Campogan, Heather Haynes, Tuyen Vu, Nadeem Anwar Sheikh, Eric Jay Small

Institutions: Herbert Irving Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Yale University, University of Southern California, USC Norris Comprehensive Cancer Center, Brigham and Women's Hospital, Harvard University, Dendreon (United States), University of California, San Francisco

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890341797

Cites:

Cited by:

Related to: 10